Skip to content
Screener

Repligen RGEN Total Assets

Total Assets at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$113.17B+11.8%
Danaher logo
DanaherDHR
$92.37B+13.2%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$713.22M-25.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$9.79B+2.8%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$7.53B-0.4%
TEC
Bio-TechneTECH
$2.55B-3.5%

Segments

By geography

See full
North America$2.34B+1.5%
Europe$489.93M+19.4%
APAC$119.59M+5.1%

Other financials

Income statement

See full
Revenue$204.1M+11.9%
Gross profit$110.0M+20.7%
Operating income$14.0M+0.6%
Net income$5.0M-66.3%
EPS (diluted)$0.09-65.4%

Balance sheet

See full
Cash & equivalents$606.8M-14.4%
Total debt$690.9M+354%
Total equity$2.1B+2.4%

Cash flow

See full
Operating cash flow$32.8M+14.5%
CapEx$5.3M-24.9%
Free cash flow$27.4M+27.5%

Valuation

See full
Market cap$8.95B+42.1%
Enterprise value$9.03B+57.3%
P/E215.5×
P/S11.6×+0.3×

Profitability

See full
Gross margin47.6%+0.9pp
Operating margin15.6%-11.0pp
Net margin17.3%-3.5pp
FCF margin22%+6.9pp

Returns & leverage

See full
Return on equity2%+1.6pp
Debt / equity0.3×+0.3×
Current ratio9.1×+0.5×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: Repligen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323773
Line itemJune 30, 2026December 31, 2025
Deferred tax assets700694
Operating lease right of use assets115,559119,538
Other noncurrent assets4,0494,913
Total assets$2,950,180$2,949,699
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable$33,233$30,010
Operating lease liabilities19,31821,559

ITEM 1. Financial Statements

FAQ

What is Repligen's total assets?
Repligen (RGEN) reported total assets of $2.95B in Q2 2026.
How has Repligen's total assets changed year-over-year?
Repligen's total assets increased by 1.7% year-over-year, from $2.9B to $2.95B.
What is the long-term trend for Repligen's total assets?
Over 5 years (2020 to 2025), Repligen's total assets has grown at a 9.2% compound annual growth rate (CAGR), from $1.9B to $2.95B.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Ask your AI about Repligen's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude